According to DataM Intelligence, the Europe Sickle Cell Disease Treatment Market was valued at approximately USD 1.12 billion in 2024 and is projected to reach USD 1.87 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2025 to 2032. The market growth is driven by rising prevalence of sickle cell disease (SCD), increasing patient awareness,...